Videos

Featured

ESC 25: STRIDE: Outcomes by Sex

Subodh Verma

Watch time: 8m 9s
ADA 25: PATHWEIGH: Weight Management in Primary Care

Leigh Perreault

Watch time: 4m 46s
ERA 25: Guideline-Based Management of CKD

Ellen Linnea Freese Ballegaard

Watch time: 3m 13s
Importance of Testing for CKD Among Patients With Type 2 Diabetes

Pam Taub, Nikolaus Marx

Watch time: 10m 51s
ACC 25 Late-Breaking Discussion: The SOUL Trial

Harriette Van Spall, Darren McGuire

Watch time: 20m 59s

Clara Bonanad Lozano, Anjay Rastogi

Simplifying Guidelines in Cardio-Kidney-Metabolic Disease

Faiez Zannad

Watch time: 13m 21s
ACC 2025: The ALPACA Phase 2 Trial

Steven E Nissen

Watch time: 2m 54s

Harold Bays, Naveed Sattar, Lydia Alexander, et al

THT 2025: The SUMMIT Trial

Barry Borlaug

Watch time: 6m 31s

Vijay Chopra, Deepak L Bhatt, George L Bakris, et al

Trending

Richard Hobbs, Lydia Alexander, Sean Wharton, et al

Watch time: 43m 12s (4 videos)

Mathew S Maurer, Margot K Davis

Watch time: 16m 10s (2 videos)

Erin D Michos, Christie Ballantyne

Watch time: 8m 4s (10 videos)

Andrew JS Coats, Stefan Anker

Top Takeaways from the 2026 Dyslipidaemia Guidelines

Ann Marie Navar

Watch time: 5m 8s

Muthiah Vaduganathan, Neha Pagidipati, Smeeta Sinha, et al

Watch time: 4h 37m 26s (7 videos)
Practice‑Changing Therapies for HFpEF/HFmrEF: SGLT2i, MRAs and Incretin Trials

Harriette Van Spall, Maja Cikes

Watch time: 22m 28s

Angela Fitch, Richard Hobbs, Nikolaus Marx, et al

Watch time: 7h 41m 27s (10 videos)

Smeeta Sinha, Navdeep Tangri, Brendon Neuen, et al

Watch time: 46m 8s (4 videos)

Fausto J Pinto, John Spertus, , et al

Watch time: 2s (19 videos)

Events

Filter by

Practice‑Changing Therapies for HFpEF/HFmrEF: SGLT2i, MRAs and Incretin Trials

Harriette Van Spall, Maja Cikes

Watch time: 22m 28s
HFA 2026: UF-CARE — Ultrafiltration in Type 2 Cardiorenal Syndrome

Guillaume Baudry

Watch time: 5m 55s
Masterclass with Dr Van Spall: Professor Zannad on Globalising Heart Failure Evidence

Faiez Zannad, Harriette Van Spall

Watch time: 19m 8s
ACC 26: CORALreef — Enlicitide for Hypercholesterolaemia

Ann Marie Navar

Watch time: 4m 5s
Top Takeaways from the 2026 Dyslipidaemia Guidelines

Ann Marie Navar

Watch time: 5m 8s
ACC 26: RECOVER-Autonomic - Ivabradine for Post-COVID POTS

Pam Taub

Watch time: 6m 14s
ACC 26: SURPASS-CVOT - Tirzepatide vs Dulaglutide in T2D

Steven E Nissen

Watch time: 4m 47s
ACC 26: MOMENTUM – Hypercortisolism in Resistant Hypertension

Deepak L Bhatt

Watch time: 6m 28s
AHA 25: HFpEF as an Adipose Tissue Disorder

Milton Packer

Watch time: 5m 43s
AHA 25: Pregnancy and CKM Health: Essential Knowledge for Cardiologists

Emily Lau

Watch time: 7m 24s

Latest

Filter by

Broadcast

Heart Failure
Hyperkalaemia in Cardiorenal Disease

Shelley Zieroth, Clara Bonanad Lozano, Andrew Frankel , et al

Watch time: 1h 34m 52s
Radcliffe & CardioNerds @AHA22: EMPA-Kidney: Empagliflozin & CV Outcomes in Patients with Chronic Kidney Disease

Kate Wilcox, David Preiss

Watch time: 18m 1s
EASD 22: SURMOUNT-MMO: Tirepatide in Obese Type II Diabetes Patients

Steven E Nissen

Watch time: 7m 48s
ESC 22: EMPEROR-Preserved & DELIVER Meta-Analysis: SGLT2is in HF

Muthiah Vaduganathan

Watch time: 5m 1s

Carolyn Lam, Scott Solomon, John JV McMurray, et al

Watch time: 1:02:16 (5 videos)
ESC 22: The EMMY Trial: Empagliflozin in Pts with Acute MI

Harald Sourij

Watch time: 2m 55s
ESC 22: FIDELITY: Finerone in Pts With Chronic Kidney Disease

Gerasimos Filippatos

Watch time: 5m 44s
ESC 22: EMPEROR-POOLED: Clinical Benefits of SGLT2i in Heart Failure

Faiez Zannad

Watch time: 4m 44s